A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.

  • Published 2008 in Clinical neuropharmacology


OBJECTIVE To report an 18-month follow-up on creatine and minocycline futility study, the Neuroprotective Exploratory Trials in Parkinson Disease, Futility Study 1 (NET-PD FS-1). BACKGROUND The NET-PD FS-1 futility study on creatine and minocycline found neither agent futile in slowing down the progression of disability in Parkinson disease (PD) at 12… (More)
DOI: 10.1097/WNF.0b013e3181342f32

4 Figures and Tables


  • Presentations referencing similar topics